Cargando…

Cost-effectiveness of adult pneumococcal conjugate vaccination in the Netherlands

The Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA) demonstrated the efficacy of 13-valent pneumococcal conjugate vaccine (PCV13) in preventing vaccine-type community-acquired pneumonia and vaccine-type invasive pneumococcal disease in elderly subjects. We examined the cost-effect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mangen, Marie-Josée J., Rozenbaum, Mark H., Huijts, Susanne M., van Werkhoven, Cornelis H., Postma, Douwe F., Atwood, Mark, van Deursen, Anna M.M., van der Ende, Arie, Grobbee, Diederick E., Sanders, Elisabeth A.M., Sato, Reiko, Verheij, Theo J.M., Vissink, Conrad E., Bonten, Marc J.M., de Wit, G. Ardine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2015
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750466/ https://www.ncbi.nlm.nih.gov/pubmed/26160871 http://dx.doi.org/10.1183/13993003.00325-2015

Ejemplares similares

Hospitalization costs for community-acquired pneumonia in Dutch elderly: an observational study
por: Vissink, Conrad E., et al.
Publicado: (2016)

Erratum to: Hospitalization costs for community-acquired pneumonia in Dutch elderly: an observational study
por: Vissink, Conrad E., et al.
Publicado: (2016)

Quality of life in community-dwelling Dutch elderly measured by EQ-5D-3L
por: Mangen, Marie-Josée J., et al.
Publicado: (2017)

The impact of 13-valent pneumococcal conjugate vaccination on virus-associated community-acquired pneumonia in elderly: Exploratory analysis of the CAPiTA trial
por: Huijts, S.M., et al.
Publicado: (2018)

Cost-effectiveness of antibiotic treatment strategies for community-acquired pneumonia: results from a cluster randomized cross-over trial
por: van Werkhoven, Cornelis H., et al.
Publicado: (2017)

The impact of community-acquired pneumonia on the health-related quality-of-life in elderly
por: Mangen, Marie-Josée J., et al.
Publicado: (2017)

Predictors of Bacteraemia in Patients with Suspected Community-Acquired Pneumonia
por: van Werkhoven, Cornelis H., et al.
Publicado: (2015)

Rationale and design of the costs, health status and outcomes in community-acquired pneumonia (CHO-CAP) study in elderly persons hospitalized with CAP
por: Mangen, Marie-Josée J, et al.
Publicado: (2013)

Invasive Pneumococcal Disease and 7-Valent Pneumococcal Conjugate Vaccine, the Netherlands
por: van Deursen, Anna M.M., et al.
Publicado: (2012)

803 Direct Costs and Duration of Hospitalization of Patients Hospitalized with Community Acquired Pneumonia: a Nationwide Retrospective Claims Database Analysis
por: Rozenbaum, Mark, et al.
Publicado: (2014)

Cardiac events after macrolides or fluoroquinolones in patients hospitalized for community-acquired pneumonia: post-hoc analysis of a cluster-randomized trial
por: Postma, Douwe F., et al.
Publicado: (2019)

Cost-effectiveness of rotavirus vaccination in the Netherlands; the results of a consensus model
por: Rozenbaum, Mark H, et al.
Publicado: (2011)

1104 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Immunogenicity in the Community Acquired Pneumonia Immunization Trial In Adults (CAPiTA)
por: Van Deursen, Anna M.M., et al.
Publicado: (2014)

595 Community Acquired Pneumonia Immunization Trial in Adults (CAPiTA)
por: Bonten, Marc, et al.
Publicado: (2014)

1439. The Cost-Effectiveness of Vaccinating Adults at Increased Risk of Pneumococcal Disease Against Pneumococcal Disease in The Netherlands
por: Rozenbaum, Mark
Publicado: (2018)

1091 Serotype Distribution of S. pneumoniae Community Acquired Pneumonia (CAP) in Adults in the Netherlands in the CAPiTA (Community-Acquired Pneumonia Immunization Trial In Adults) Study Period
por: Hollingsworth, Rosalind, et al.
Publicado: (2014)

Routine vaccination for influenza and pneumococcal disease and its effect on COVID-19 in a population of Dutch older adults
por: Taks, Esther J.M., et al.
Publicado: (2023)

Adaptive designs in clinical trials in critically ill patients: principles, advantages and pitfalls
por: van Werkhoven, C. H., et al.
Publicado: (2018)

Targeted rotavirus vaccination of high-risk infants; a low cost and highly cost-effective alternative to universal vaccination
por: Bruijning-Verhagen, Patricia, et al.
Publicado: (2013)

Confounding by indication of the safety of de-escalation in community-acquired pneumonia: A simulation study embedded in a prospective cohort
por: van Heijl, Inger, et al.
Publicado: (2019)

Sex differences in invasive pneumococcal disease and the impact of pneumococcal conjugate vaccination in the Netherlands, 2004 to 2015
por: Wagenvoort, Gertjan H J, et al.
Publicado: (2017)

1434. Cost-Effectiveness of Sequencial Vaccination With the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Followed by the 23 Valent Polysaccharide Vaccine (PPV23) in The Netherlands
por: Rozenbaum, Mark
Publicado: (2018)

Reanalysis of the Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children < 5 Age: A Societal Perspective
por: Li, Xiuyan, et al.
Publicado: (2023)

Invasive Pneumococcal Disease 3 Years after Introduction of 10-Valent Pneumococcal Conjugate Vaccine, the Netherlands
por: Knol, Mirjam J., et al.
Publicado: (2015)

Vaccination of risk groups in England using the 13 valent pneumococcal conjugate vaccine: economic analysis
por: Rozenbaum, Mark H, et al.
Publicado: (2012)

Cost-effectiveness of alternative strategies for use of 13-valent pneumococcal conjugate vaccine (PCV13) in Canadian adults
por: Atwood, Mark, et al.
Publicado: (2018)

The impact of circadian rhythm on Bacillus Calmette-Guérin vaccination effects on SARS-CoV-2 infections
por: Föhse, Konstantin, et al.
Publicado: (2023)

Four key signaling pathways mediating chemotaxis in Dictyostelium discoideum
por: Veltman, Douwe M., et al.
Publicado: (2008)

1738. Cost-Effectiveness Analysis of Infant Pneumococcal Vaccination with the 20-Valent Pneumococcal Conjugate in the US
por: Rozenbaum, Mark, et al.
Publicado: (2023)

Antibiotic rotation strategies to reduce antimicrobial resistance in Gram-negative bacteria in European intensive care units: study protocol for a cluster-randomized crossover controlled trial
por: van Duijn, Pleun J, et al.
Publicado: (2014)

Quantifying Cost-Effectiveness of Controlling Nosocomial Spread of Antibiotic-Resistant Bacteria: The Case of MRSA
por: Wassenberg, Marjan W. M., et al.
Publicado: (2010)

Cost-effectiveness of selective digestive decontamination (SDD) versus selective oropharyngeal decontamination (SOD) in intensive care units with low levels of antimicrobial resistance: an individual patient data meta-analysis
por: van Hout, Denise, et al.
Publicado: (2019)

The impact of Bacillus Calmette-Guérin vaccination on antibody response after COVID-19 vaccination
por: Taks, Esther J.M., et al.
Publicado: (2023)

Inappropriate Use of Antimicrobials for Lower Respiratory Tract Infections in Elderly Patients: Patient- and Community-Related Implications and Possible Interventions
por: van Heijl, Inger, et al.
Publicado: (2018)

Famine Exposure in the Young and the Risk of Type 2 Diabetes in Adulthood
por: van Abeelen, Annet F.M., et al.
Publicado: (2012)

Activation of Hepatic Lipase Expression by Oleic Acid: Possible Involvement of USF1
por: van Deursen, Diederik, et al.
Publicado: (2009)

A Model-based Assessment of Oseltamivir Prophylaxis Strategies to Prevent Influenza in Nursing Homes
por: van den Dool, Carline, et al.
Publicado: (2009)

Effectiveness of extended- versus normal-release nitrofurantoin for cystitis: an instrumental variable analysis
por: ten Doesschate, Thijs, et al.
Publicado: (2019)

Is quantitative ultrasound a measure for metabolic bone disease in preterm-born infants? A prospective subcohort study
por: de Lange, A., et al.
Publicado: (2021)

Community-Acquired Pneumonia—Back to Basics
por: Bonten, Marc J.M., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_8nu98aj4jt7amudehsnpktiqfl